Aquestive Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Aquestive Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aquestive Therapeutics Inc
Rating: 1.67525
Author: Trendlyne DVM scores

about

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

4.04 0.01 (0.25%)

30.34% Fall from 52W High

602.7K

XNAS Volume

XNAS 15 Jul, 2025 12:22 PM (EDT)

Not Eligible

Expensive Valuation

7.5 / 100

Technically Neutral

59.5 / 100

1Yr Price target upside is 108%

9 analysts

Aquestive Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aquestive Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

30.34% Fall from 52W High

SWOT Analysis

Aquestive Therapeutics Inc Live Price Chart